Aphria Inc reported CAD160.92M in Cost of Sales for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Ani Pharmaceuticals ANIP:US $ 24.41M 2.1M
Aurora Cannabis Inc ACB:CN 46M 69.67M
Canopy Growth Corp WEED:CN C$ 202.51M 93.54M
Corcept Therapeutics CORT:US $ 1.27M 0.11M
Cronos Group Inc CRON:CN 31.41M 15.83M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Lannett LCI:US $ 85M 1.65M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M